Enveric Biosciences, Inc.
ENVB
$5.32
$0.224.31%
NASDAQ
Corporate Info
Website
Phone Number
617 444 8400
Address
245 First Street
Riverview II
18 th Floor
Cambridge, MA 02142
Riverview II
18 th Floor
Cambridge, MA 02142
Country
United States
Year Founded
--
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.